logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shengjie Cui

northwell health
H指数:23
被引数:1,524

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sinonasal Inverted Papilloma and Clinical Significance of Dysplasia: A Multi-Institutional Study
LARYNGOSCOPE
IF2
2025-11-011
PRE
Kim, Alexis H.; Tham, Tristan; Giannaris, Peter S.; Kokabee, Mostafa; Wilensky, Jadyn; Tsang, Cynthia; Wang, Beverly Y.; Panara, Kush; Kuan, Edward C.; Papagiannopoulos, Peter; Tajudeen, Bobby; Eide, Jacob G.; Craig, John R.; Kshirsagar, Rijul S.; Christian, Zachary; Locke, Tran B.; Fastenberg, Judd H.; Chaskes, Mark B.; Pollack, Aron Z.; Har-el, Gady; Cui, Shengjie; Guerrero, Dominick; Ahn, Seungjun; Oh, Eun Jeong; Workman, Alan D.; Kohanski, Michael A.; Douglas, Jennifer; Robertson, Erle S.; Jalaly, Jalal; Adappa, Nithin D.; Palmer, James N.; Tong, Charles C. L.
Effects of orthodontic camouflage treatment vs orthodontic-orthognathic surgical treatment on condylar stability in Class II hyperdivergent patients with severe temporomandibular joint osteoarthrosis: a retrospective observational study

正畸伪装治疗与正畸-正颌手术治疗对重度颞下颌关节骨关节病 ⅱ 级高发散症患者髁突稳定性的影响: 一项回顾性观察研究

ANGLE ORTHODONTIST
IF3.2
2023-03-131
OA
Tian, Yajing; Mao, Bochun; Cui, Shengjie; Guo, Yanning; Zhao, Ningrui; Zhang, Yidan; Zhou, Yanheng; Wang, Xuedong
PALOMA-4: Primary results from a phase III trial of palbociclib (PAL) plus letrozole (LET) vs placebo (PBO) plus LET in Asian postmenopausal women with estrogen receptore positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced breast cancer (ABC)
ANNALS OF ONCOLOGY
IF65.4
2021-09-0112
OAAI
Xu, B.; Hu, X.; Li, W.; Sun, T.; Shen, K.; Wang, S.; Cheng, Y.; Zhang, Q.; Cui, S.; Tong, Z.; Geng, C.; Huang, C-S.; Sriuranpong, V.; Ngan, K. C. R.; Chia, Y. H.; Wang, X.; Zhao, H.
Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial
ANNALS OF ONCOLOGY
IF65.4
2021-02-0124
OAAI
Xu, B.; Sun, T.; Zhang, Q.; Zhang, P.; Yuan, Z.; Jiang, Z.; Wang, X.; Cui, S.; Teng, Y.; Hu, X-C; Yang, J.; Pan, H.; Tong, Z.; Li, H.; Yao, Q.; Wang, Y.; Yin, Y.; Sun, P.; Zheng, H.; Cheng, J.; Lu, J.; Zhang, B.; Geng, C.; Liu, J.; Shen, K.; Yu, S.; Tang, L.; Qiu, R.

研究方向

暂未获取到该数据
Y
Yan Liu
H 指数:51论文数:338被引数:9,519
Y
Yanheng Zhou
H 指数:37论文数:148被引数:4,961
Y
Yehua Gan
H 指数:28论文数:94被引数:2,960
周衍衡 封面图
周衍衡
H 指数:27论文数:70被引数:2,152
R
Ruili Yang
H 指数:32论文数:94被引数:4,421
Y
Yu Fu
H 指数:12论文数:22被引数:802
X
Xiaoxing Kou
H 指数:41论文数:90被引数:5,298
王铁 封面图
王铁
H 指数:62论文数:445被引数:1.2万
Y
Yikun Zhou
H 指数:8论文数:43被引数:397
罗
罗聃
H 指数:52论文数:434被引数:1.0万